NVS/MNTA defense arguments in Copaxone patent case: 208.78.96.220/NVS-MNTA_defense_arguments.pdf Click here for Court document (8/24/11; 6 pages) A. Non-infringement B. Invalidity • Obviousness • Lack of Enablement • Indefiniteness* • Lack of Best Mode C. Unenforceability (inequitable conduct) *Summary judgment denied by Court (#msg-54139320, #msg-66626914). Thanks to ‘mouton29’ for making this document available.